Sakai, Japan

Satoshi Horii


Average Co-Inventor Count = 2.5

ph-index = 6

Forward Citations = 113(Granted Patents)


Location History:

  • Osaka, JA (1976 - 1977)
  • Sakai, JA (1977 - 1978)
  • Sakai, JP (1984 - 1990)
  • Osaka, JP (1989 - 1991)

Company Filing History:


Years Active: 1976-1991

Loading Chart...
21 patents (USPTO):Explore Patents

Title: Satoshi Horii: Innovator in Pharmaceutical Compounds

Introduction

Satoshi Horii is a prominent inventor based in Sakai, Japan, known for his significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 21 patents, his work focuses on innovative compounds that address critical health issues, particularly those related to glucose metabolism and diabetes.

Latest Patents

Among his latest inventions, Satoshi has developed novel inosose derivatives and pseudo-aminosugars. His patent on inosose derivatives details a unique compound that serves as an intermediate for the production of valiolamine and its N-substituted derivatives, which demonstrate potent alpha-glucosidase inhibiting activities. These compounds are particularly promising as therapeutics for hyperglycemia, diabetes, obesity, and associated disorders in both humans and animals.

Another significant achievement is his patent concerning pseudo-aminosugars, specifically 5-amino-1-hydroxymethyl-1,2,3,4-cyclohexanetetrol. This compound also shows excellent alpha-glucosidase inhibitory activity and offers potential benefits for treating various hyperglycemic symptoms.

Career Highlights

Satoshi Horii's career is marked by his role at Takeda Chemical Industries, Inc., a leading pharmaceutical company. His innovative spirit and scientific expertise have led to the development of several impactful compounds, enhancing the company's portfolio in therapeutic treatments. His work not only highlights his talent as an inventor but also underscores the importance of continuous innovation in the healthcare sector.

Collaborations

Throughout his career, Satoshi Horii has collaborated with esteemed colleagues, including Yukihiko Kameda and Hiroshi Fukase. Their collaborative efforts have contributed to the advancement of research in pharmaceuticals, fostering a rich environment of innovation and discovery in the field.

Conclusion

Satoshi Horii exemplifies the spirit of innovation within the pharmaceutical industry. His patent portfolio reflects a commitment to addressing significant health challenges through scientific research and development. With ongoing contributions to drug discovery and development, Satoshi continues to be a vital player in transforming medical treatments for conditions related to glucose metabolism and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…